Wuhan
Wuhan
Wuhan, Hebei, China9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 3 | 2026-09-18 | NCT06722235 | |
| A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 3 | 2026-09-09 | NCT06948318 | |
| A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors | Advanced Solid Tumors | Active, not recruiting | Phase 1 | 2026-08-07 | NCT05502393 | |
| Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, gastric cancer, gastric neoplasm, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm, stomach disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-30 | NCT06710132 | |
| AI-Driven IOL Prediction Using SS-OCT Biometry | cataract, eye disorder, lens disorder | Not yet recruiting | Not stated | 2026-07-29 | NCT07733154 | |
| China HeadAche DIsorders RegiStry | Analgesic Overuse Headache, Headache Disorders, Secondary, Tension-Type Headache, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder, trigeminal autonomic cephalalgia | Recruiting | Not stated | 2026-07-10 | NCT05334927 | |
| Xuan Yin Ning Plus Bevacizumab for Malignant Pleural Effusion | Neoplasms by Site, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, myeloproliferative disorder, chronic, with eosinophilia, neoplasm, pleural disorder, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not applicable | 2026-07-01 | NCT07670338 | |
| A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 2 | 2026-06-03 | NCT07303803 | |
| Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Not yet recruiting | Phase 2 | 2023-08-15 | NCT05993858 |